跳至主要内容
临床试验/NCT06253351
NCT06253351已完成不适用

Real-world Use of Hybrid Closed Loop in Adolescents and Young Adults 15-25 Years of Age with Type 1 Diabetes

Centre Hospitalier Sud Francilien1 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2024年3月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
101
试验地点
1
主要终点
HbA1c after HCL

研究概览

简要总结

The purpose of this study is to determine the effect of hybrid closed loop on glycemic outcomes in young patients aged between 15 and 25 years old with type 1 diabetes, whatever is their initial metabolic control.

详细描述

Type 1 diabetes (T1D) constitutes a major public health challenge due to acute complications requiring emergency hospitalizations, as well as many chronic complications that need to be managed over the long term. However, these complications can be prevented by maintaining correct glycemic control, according to international guidelines.

For the past few years, the arrival of new technologies as insulin pump and particularly Continuous Glucose Monitoring (CGM) showed a significant improvement on metabolic control.

Nevertheless, adolescents and young adults with type 1 diabetes need a special focus because they still fail to meet glycemic control targets.

At this time, hybrid closed loop, pairing Continuous Glucose Monitoring with insulin pump, enables insulin delivery in a semi-autonomous way thanks to algorithms, and leads to the best metabolic results we've never got in randomized trials and real-world studies.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
15 Years 至 25 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patient aged between 15 and 25 years old
  • Type 1 diabetes since at least 1 year at the moment of instauring HCL
  • At least 3 months of HCL use

排除标准

  • Informed patient that have been opposed for their data collect

结局指标

主要结局

HbA1c after HCL

时间窗: at 3 months

Comparison of HbA1c (%) before and after HCL (at least 3 months of use)

次要结局

  • nephropathy(at 3 months)
  • Use of HCL(at 3 months)
  • Glycemic parameters with CGM(at 3 months)
  • keto-acidosis and severe hypoglycemia(at 3 months)
  • retinopathy(at 3 months)
  • HbA1c after HCL(at 24 months)
  • HCL stop(at 3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验